Rising coronavirus infections in some regions could lead to a fourth spike in US cases.
The Biden administration reached an important target – by April 2, 100 million US residents had received at least one dose of the COVID-19 vaccine.
The United States became the first country in the world to achieve such success in vaccination. However, in some regions of the United States, the number of cases of COVID-19 infection continues to grow.
Earlier this week, President Joe Biden said that due to the increase in vaccination rate, at least 90% of American adults would be eligible for the vaccine by April 19. Earlier, Biden promised to achieve this figure by May 1.
However, during a coronavirus working group briefing at the White House earlier this week, the head of the US Centers for Disease Control and Prevention (CDC), Dr. Rochelle Walensky, warned of the danger of too many Americans ceasing to comply with the restrictions associated with COVID-19.
President Biden suggested that if this trend continues, there could be a fourth spike in COVID-19 infections in the US.
Compared to the United States, European countries are lagging in implementing vaccination programs. The World Health Organization reported that only 10% of the European population received one vaccine dose, and only 4% received two doses.
One of the reasons for this lag is the EU’s dependence on the AstraZeneca vaccine, which is plagued by troubles – in particular, many countries report complications after this vaccine-related to blood clotting. The Netherlands on Friday followed the lead of Germany, which stopped using the vaccine for people under 60.
Cases of blood clots in connection with this vaccine are sporadic. The European Medicines Agency said the AstraZeneca vaccine is safe.
“We have to be careful, so it would be wise to press the pause button now as a precautionary measure,” Dutch Health Minister Hugo de Jonge said in a statement.